RT Journal Article
SR Electronic
T1 Covid-19 Belgium: Extended SEIR-QD model with nursing homes and long-term scenarios-based forecasts
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.09.07.20190108
DO 10.1101/2020.09.07.20190108
A1 Nicolas Franco
YR 2020
UL http://medrxiv.org/content/early/2020/11/04/2020.09.07.20190108.abstract
AB We model the evolution of the covid-19 epidemic in Belgium with an age-structured extended SEIR-QD epidemic model with separated consideration for nursing homes. All parameters of the model are estimated using a MCMC method, except integrated data on social contacts. The model is calibrated on hospitals’ data, number of deaths, nursing homes’ tests and serological tests. We present the current situation in November 2020 as well as long-term scenarios-based forecasts concerning the second wave and subsequent lifting of measures.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Namur Institute for Complex Systems (naXys) and the Department of Mathematics of the University of Namur, Belgium. The funding source played no role in study design, in the collection, analysis and interpretation of data, in the writing of the repor; and in the decision to submit the article for publication.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:not applicableAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll used data are available on the website of the Belgian Scientific Institute for Public Health, Sciensano. https://epistat.wiv-isp.be/Covid/